"Star offers a unique proposition to play the fastest growing segment in the general insurance space. Given the market leadership in the retail health business, strong earnings growth prospects (25 per cent plus CAGR), limited cyclicality risk (commercial lines and motor insurance have high cyclicality), and healthy RoE profile (15–17 per cent over the medium term), we believe the stock deserves a premium,
Source : Economic times
Source : Economic times